Published on 28 Oct 2021 on Simply Wall St. via Yahoo Finance
CryoLife (NYSE:CRY) shareholders have endured a 33% loss from investing in the stock three years ago
As an investor its worth striving to ensure your overall portfolio beats the market average. But the risk of stock picking is that you will likely buy under-performing companies. Unfortunately, that's been the case for longer term CryoLife, Inc. (NYSE:CRY) shareholders, since the share price is down 33% in the last three years, falling well short of the market return of around 79%. The falls have accelerated recently, with the share price down 25% in the last three months.
So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress.
View our latest analysis for CryoLife